These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16075925)

  • 41. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to orbital tissues in thyroid-associated ophthalmopathy.
    Perros P; Kendall-Taylor P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):137-42. PubMed ID: 1543019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.
    Kendall-Taylor P; Atkinson S; Holcombe M
    Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1183-6. PubMed ID: 6424781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy.
    Pasquali D; Vassallo P; Esposito D; Bonavolontà G; Bellastella A; Sinisi AA
    J Mol Endocrinol; 2000 Aug; 25(1):63-71. PubMed ID: 10915219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of immune damage in Graves' ophthalmopathy.
    Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
    Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
    Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Definition, at the molecular level, of a thyroglobulin-acetylcholinesterase shared epitope: study of its pathophysiological significance in patients with Graves' ophthalmopathy.
    Ludgate M; Dong Q; Dreyfus PA; Zakut H; Taylor P; Vassart G; Soreq H
    Autoimmunity; 1989; 3(3):167-76. PubMed ID: 2485081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
    McLachlan SM; Bahn R; Rapoport B
    Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
    Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
    J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
    Bahn RS; Dutton CM; Joba W; Heufelder AE
    Thyroid; 1998 Feb; 8(2):193-6. PubMed ID: 9510130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO).
    Rotondo Dottore G; Ionni I; Menconi F; Casini G; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2018 Jul; 41(7):815-820. PubMed ID: 29256181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
    Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
    Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide.
    Wall JR; Strakosch CR; Fang SL; Ingbar SH; Braverman LE
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):79-91. PubMed ID: 582025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin E2 alters human orbital fibroblast shape through a mechanism involving the generation of cyclic adenosine monophosphate.
    Wang HS; Keese CR; Giaever I; Smith TJ
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3553-60. PubMed ID: 8530598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy.
    Heufelder AE
    Thyroid; 1995 Aug; 5(4):331-40. PubMed ID: 7488878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy.
    Chen B; Tsui S; Smith TJ
    J Immunol; 2005 Jul; 175(2):1310-9. PubMed ID: 16002736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.